IM Cannabis (IMCC) Consolidated Net Income (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Consolidated Net Income of -$1.8 million for Q1 2026, down 1575.03% year-over-year from $121960.4 in Q1 2025, and up 75.88% quarter-over-quarter from -$7.5 million in Q4 2025.
IM Cannabis (IMCC) Consolidated Net Income (2020 - 2026) Analysis & Trends
IM Cannabis' Consolidated Net Income history runs 7 years deep, the most recent figure standing at -$1.8 million for Q1 2026.
- In Q1 2026, Consolidated Net Income fell 1575.03% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at -$13.0 million (down 666.68% YoY), while the FY2025 annual figure was -$10.2 million, changed N/A from the prior year.
- Consolidated Net Income for Q1 2026 stood at -$1.8 million, up from -$7.5 million in the prior quarter.
- The five-year high for Consolidated Net Income was $1.6 million in Q3 2023, with the low at -$94.8 million in Q3 2022.
- The 5-year median for Consolidated Net Income is -$2.3 million (2026), against an average of -$9.9 million.
- The sharpest annual moves came in 2022 and 2025: Consolidated Net Income tumbled 1939.92% in 2022, then jumped 102.73% in 2025.
- IM Cannabis' Consolidated Net Income stood at -$17.5 million in 2022, then increased by 23.19% to -$13.5 million in 2023, then soared by 91.36% to -$1.2 million in 2024, then sank by 541.23% to -$7.5 million in 2025, then soared by 75.88% to -$1.8 million in 2026.
- Business Quant data shows IMCC's Consolidated Net Income at -$1.8 million in Q1 2026, -$7.5 million in Q4 2025, and -$2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | -3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.17 Mn |
| Mar 31, 2026 | -1.80 Mn |
| Dec 31, 2025 | -7.46 Mn |
| Sep 30, 2025 | -2.81 Mn |
| Jun 30, 2025 | -899,253.77 |
| Mar 31, 2025 | 121,960.38 |
| Dec 31, 2024 | -1.16 Mn |
| Sep 30, 2024 | -793,163.79 |
| Jun 30, 2024 | 143,303.55 |
| Mar 31, 2024 | -4.47 Mn |
| Dec 31, 2023 | -13.47 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | -664,247.34 |
| Dec 31, 2022 | -17.53 Mn |
| Sep 30, 2022 | -94.80 Mn |
| Jun 30, 2022 | -11.98 Mn |
| Mar 31, 2022 | -2.89 Mn |
| Dec 31, 2021 | -25.05 Mn |
| Sep 30, 2021 | 5.15 Mn |
| Jun 30, 2021 | -4.14 Mn |